Stimwave Technologies Incorporated
USPTO PatentsView assignee record - 39 granted patents across 10 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).
The verdict
According to USPTO PatentsView, Stimwave ranks #8,293 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 10 technology areas.
- #8,293
- of 49,997 US assignees by volume
- Top 44%
- by Innovation Score (37.3/100)
- 18.5
- avg claims per patent
- +29%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R8293 · US Corporation #8,293 · 39 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 39 grants
- UPPER-Q #8,293/49,997
- PHOTO-FINISH SetPoint Medical
- CPC-FOCUS A61N · 10 areas
- INNOV-THIN 37.3/100
- CLAIMS-RICH 18.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +29% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: SetPoint Medical Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Stimwave’s 37.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Stimwave
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Bbpos · near
Bbpos · near
37 score
- Card-Monroe · near
Card-Monroe · near
37 score
- Global Nuclear… · near
Global Nuclear… · near
37 score
- Interblock D O O · near
Interblock D O O · near
37 score
- Stimwave Incorporated · this assignee
Stimwave Incorporated · this assignee
37 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Stimwave's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Stimwave?
Each dot is one of Stimwave’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stimwave’s own 18.5 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Stimwave's grants concentrate
Stimwave Technologies Incorporated is a focused PatentsView assignee: 10 CPC subclasses with 94.9% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2019 (17 grants) versus a trough of 4 in 2020. By volume, Stimwave sits between SetPoint Medical Corporation and Toyo Jidoki Co., Ltd..
Stimwave's three-year grant acceleration
From 2019–2021 to 2022–2024, Stimwave Technologies Incorporated moved from 29 to 10 grants (0.34x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Stimwave's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Setpoint Medical
SetPoint Medical Corporation
39 patents
- Singapore Univers…
Singapore University of Technology and Design
39 patents
- Slayback Pharma
Slayback Pharma LLC
39 patents
- Slice
Slice, Inc.
39 patents
- T-max (Hangzhou)…
T-max (HANGZHOU) Technology, Co., Ltd.
39 patents
- Thunder Power Hon…
Thunder Power Hong Kong Ltd.
39 patents
- TM IP Holdings
TM IP Holdings, LLC
39 patents
- Toyo Jidoki
Toyo Jidoki Co., Ltd.
39 patents
- Stimwave Incorpor… ◀
Stimwave Technologies Incorporated
39 patents
What this shows Stimwave holds 39 patents at rank #8,292, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Stimwave
By rank, the assignees closest to #8,292 in granted patent volume.
- SetPoint Medical Corporation #8,288 · 39 patents
- Singapore University of Technology and Design #8,289 · 39 patents
- Slayback Pharma LLC #8,290 · 39 patents
- Slice, Inc. #8,291 · 39 patents
- T-max (HANGZHOU) Technology, Co., Ltd. #8,293 · 39 patents
- Thunder Power Hong Kong Ltd. #8,294 · 39 patents
- TM IP Holdings, LLC #8,295 · 39 patents
- Toyo Jidoki Co., Ltd. #8,296 · 39 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in Stimwave's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- Zoll Medical Corporation 556 in class
- Koniniklijke Philips N.V. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Stimwave, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Stimwave ranks #103 of 1,943 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (37 here).
Stimwave's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 44% higher than 56% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 17 | 43.6% |
| 2020 | 4 | 10.3% |
| 2021 | 8 | 20.5% |
| 2022 | 6 | 15.4% |
| 2023 | 4 | 10.3% |
Which technologies does Stimwave Technologies Incorporated patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Stimwave Technologies Incorporated's patent record in context - here's where to go next.
- Stimwave Technologies Incorporated's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 94.9% of its portfolio - see every assignee active in that class. Explore A61N
- Ranked #8,293 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Stimwave Technologies Incorporated against SetPoint Medical Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.